Filing Details
- Accession Number:
- 0001672688-24-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-14 16:40:55
- Reporting Period:
- 2024-06-13
- Accepted Time:
- 2024-06-14 16:40:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1672688 | Absci Corp | ABSI | Services-Commercial Physical & Biological Research (8731) | 853383487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1872568 | Zachariah Jonasson | C/O Absci Corporation 18105 Se Mill Plain Blvd Vancouver WA 98683 | Cfo / Cbo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-13 | 28,700 | $3.39 | 404,610 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-06-13 | 19,859 | $4.98 | 384,751 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2024-06-13 | 28,700 | $0.00 | 28,700 | $3.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2032-06-07 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.93 to $5.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The stock option was exercised on June 13, 2024, as it would have terminated on June 30, 2024 (six months after the Reporting Person's resignation from the Issuer's board of directors effective on December 31, 2023) per the Non-Qualified Stock Option Agreement for Non-Employee Directors under the Absci Corporation 2021 Stock Option and Incentive Plan and the Issuer's Amended and Restated Non-Employee Director Compensation Policy.
- The stock option was fully vested.